A PUBLIC SUCCESS: Dr. Anne S. De Groot, CEO and chief strategy officer of EpiVax, and William Martin, chief information and operating officer, have been able to use public investments through the years to make breakthroughs in immunology and other fields. / PBN PHOTO/MICHAEL SALERNO
Dr. Anne S. De Groot is a major success story, not just in Rhode Island but across the globe. She bridges the research and clinical aspects of medicine unlike many others, founding and still leading EpiVax Inc., the growing venture that is getting more and more traction for its toolkit to analyze, design and produce…
You must be a paid subscriber to read this content.
To keep reading and receive unlimited access subscribe today for only $1.
Subscribe NowAlready a Subscriber?
Login now
Want to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.
Want to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.
